About Contact Us Careers

Cardiometabolic Drugs Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4146
Published Date: Dec 20, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Cardiometabolic Drugs Landscape

GSK plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Lupin Limited
Merck KGaA
Romark L.C.
Pfizer Inc.
Endo International plc
Bayer AG
Jazz Pharmaceuticals plc
Canopy Growth Corporation
InMed Pharmaceuticals Inc.

Browse Key Market Insights with Data Illustration:

Cardiometabolic Drugs Market Size & Share, Growth Forecasts 2025-2037

In the News

GSK plc acquires the approval from US Food and Drug Administration (FDA) for its Priorix, a vaccine for mumps, measles, and rubella in children 12 months old or above it.
Lupin Limited to merge its path with Yabao Pharmaceutical Co., inc., based in China, to fulfill the escalating demand in the Chinese market for quality drugs with the pediatric formulation.

Author Credits: Radhika Pawar

Report ID: 4146
Published Date: Dec 20, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cardiometabolic drugs is evaluated at USD 62.07 billion.

The cardiometabolic drugs market size was valued at USD 56.34 billion in 2024 and is expected to reach USD 123.15 billion by 2037, expanding at around 6.2% CAGR during the forecast period i.e., between 2025-2037. Increasing awareness toward the development of novel drugs and the growing demand for drugs to cure cardiometabolic diseases will boost the market growth.

North America industry is expected to dominate majority revenue share by 2037, on the back of presence of multiple key players in the region and higher prevalence of cardiovascular diseases and usage ofÃ‚Â cardiovascular devices.

The major players in the market are GSK plc, Lupin Limited, Merck KGaA, Romark L.C., Pfizer Inc., Endo International plc, Bayer AG, Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc.

Inquiry Before Buying Request Free Sample